AN2 Therapeutics SG&A Expense (Quarterly) Trends

AN2 Therapeutics Inc (ANTX)

2.17 +0.18 (+9.05%) USD | NASDAQ | Jun 14, 16:00

2.15 -0.02 (-0.92%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2021. Upgrade now.

Date	Value
March 31, 2024	3.641M
December 31, 2023	3.896M
September 30, 2023	3.751M
June 30, 2023	3.063M
March 31, 2023	4.054M
December 31, 2022	3.724M
September 30, 2022	3.342M

Date	Value
June 30, 2022	3.635M
March 31, 2022	2.05M
December 31, 2021	1.782M
September 30, 2021	1.587M
June 30, 2021	0.898M
March 31, 2021	0.401M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.401M

Minimum

Mar 2021

4.054M

Maximum

Mar 2023

2.756M

Average

3.342M

Median

Sep 2022

SG&A Expense (Quarterly) Benchmarks